Filing Details

Accession Number:
0001140361-14-046532
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-29 14:36:52
Reporting Period:
2014-12-23
Filing Date:
2014-12-29
Accepted Time:
2014-12-29 14:36:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
926617 Vermillion Inc. VRML In Vitro & In Vivo Diagnostic Substances (2835) 330595156
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
924141 P L Partners Institutional Oracle C/O Oracle Investment Management, Inc.
200 Greenwich Avenue
Greenwich CT 06830
No No Yes Yes
926475 N Larry Feinberg C/O Oracle Investment Management, Inc.
200 Greenwich Avenue
Greenwich CT 06830
No No Yes Yes
941901 Oracle Partners Lp C/O Oracle Investment Management, Inc.
200 Greenwich Avenue
Greenwich CT 06830
No No Yes Yes
1012622 Oracle Investment Management Inc 200 Greenwich Avenue
Greenwich CT 06830
No No Yes Yes
1317217 Oracle Associates Llc C/O Oracle Investment Management, Inc.
200 Greenwich Avenue
Greenwich CT 06830
No No Yes Yes
1577258 Oracle Ten Fund Master, Lp C/O Oracle Investment Management, Inc.
200 Greenwich Avenue
Greenwich CT 06830
No No Yes Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Acquisiton 2014-12-23 972,222 $1.44 8,112,182 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants to acquire Common Stock Acquisiton 2014-12-23 583,333 $0.00 583,333 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-06-23 2017-12-23 No 4 P Indirect
Footnotes
  1. See Exhibit 99.1, Note 1.
  2. See Exhibit 99.1, Note 2.
  3. See Exhibit 99.1, Note 3.